Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

BeOne Medicines (BEIGF) Return on Assets (2016 - 2025)

Historic Return on Assets for BeOne Medicines (BEIGF) over the last 10 years, with Q3 2025 value amounting to 0.01%.

  • BeOne Medicines' Return on Assets rose 1600.0% to 0.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01%, marking a year-over-year increase of 1600.0%. This contributed to the annual value of 0.11% for FY2024, which is 500.0% up from last year.
  • Latest data reveals that BeOne Medicines reported Return on Assets of 0.01% as of Q3 2025, which was up 1600.0% from 0.03% recorded in Q2 2025.
  • BeOne Medicines' Return on Assets' 5-year high stood at 0.01% during Q3 2025, with a 5-year trough of 0.34% in Q1 2023.
  • In the last 5 years, BeOne Medicines' Return on Assets had a median value of 0.21% in 2021 and averaged 0.19%.
  • Per our database at Business Quant, BeOne Medicines' Return on Assets crashed by -1200bps in 2022 and then surged by 2000bps in 2024.
  • Over the past 5 years, BeOne Medicines' Return on Assets (Quarter) stood at 0.21% in 2021, then tumbled by -57bps to 0.33% in 2022, then surged by 53bps to 0.16% in 2023, then increased by 29bps to 0.11% in 2024, then soared by 109bps to 0.01% in 2025.
  • Its last three reported values are 0.01% in Q3 2025, 0.03% for Q2 2025, and 0.07% during Q1 2025.